Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2006 3
2008 1
2009 1
2010 3
2011 1
2013 2
2015 1
2017 1
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
RHOJ controls EMT-associated resistance to chemotherapy.
Debaugnies M, Rodríguez-Acebes S, Blondeau J, Parent MA, Zocco M, Song Y, de Maertelaer V, Moers V, Latil M, Dubois C, Coulonval K, Impens F, Van Haver D, Dufour S, Uemura A, Sotiropoulou PA, Méndez J, Blanpain C. Debaugnies M, et al. Among authors: coulonval k. Nature. 2023 Apr;616(7955):168-175. doi: 10.1038/s41586-023-05838-7. Epub 2023 Mar 22. Nature. 2023. PMID: 36949199 Free PMC article.
Regulation of CDK4.
Bockstaele L, Coulonval K, Kooken H, Paternot S, Roger PP. Bockstaele L, et al. Among authors: coulonval k. Cell Div. 2006 Nov 8;1:25. doi: 10.1186/1747-1028-1-25. Cell Div. 2006. PMID: 17092340 Free PMC article.
CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM, Raspé E, Coulonval K, Decaussin-Petrucci M, Tarabichi M, Dom G, Libert F, Craciun L, Andry G, Wicquart L, Leteurtre E, Trésallet C, Marlow LA, Copland JA, Durante C, Maenhaut C, Cavaco BM, Dumont JE, Costante G, Roger PP. Pita JM, et al. Among authors: coulonval k. Front Endocrinol (Lausanne). 2023 Oct 26;14:1247542. doi: 10.3389/fendo.2023.1247542. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37964967 Free PMC article.
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4.
Gonzalez-Valero A, Reeves AG, Page ACS, Moon PJ, Miller E, Coulonval K, Crossley SWM, Xie X, He D, Musacchio PZ, Christian AH, McKenna JM, Lewis RA, Fang E, Dovala D, Lu Y, McGregor LM, Schirle M, Tallarico JA, Roger PP, Toste FD, Chang CJ. Gonzalez-Valero A, et al. Among authors: coulonval k. J Am Chem Soc. 2022 Dec 21;144(50):22890-22901. doi: 10.1021/jacs.2c04039. Epub 2022 Dec 9. J Am Chem Soc. 2022. PMID: 36484997 Free PMC article.
Inhibitory effects of 2-iodohexadecanal on FRTL-5 thyroid cells proliferation.
Thomasz L, Coulonval K, Salvarredi L, Oglio R, Fusco A, Rossich L, Pisarev MA, Roger PP, Juvenal GJ. Thomasz L, et al. Among authors: coulonval k. Mol Cell Endocrinol. 2015 Mar 15;404:123-31. doi: 10.1016/j.mce.2015.01.038. Epub 2015 Feb 2. Mol Cell Endocrinol. 2015. PMID: 25657048
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib.
Raspé E, Coulonval K, Pita JM, Paternot S, Rothé F, Twyffels L, Brohée S, Craciun L, Larsimont D, Kruys V, Sandras F, Salmon I, Van Laere S, Piccart M, Ignatiadis M, Sotiriou C, Roger PP. Raspé E, et al. Among authors: coulonval k. EMBO Mol Med. 2017 Aug;9(8):1052-1066. doi: 10.15252/emmm.201607084. EMBO Mol Med. 2017. PMID: 28566333 Free PMC article.
21 results